课题基金 / 基金详情

ADENOVIRUS E1A PROTEIN AND THE SWI/SNF COMPLEX

ADENOVIRUS E1A PROTEIN AND THE SWI/SNF COMPLEX
腺病毒 E1A 蛋白和 SWI/SNF 复合物
批准号:
6287364
负责人:
DANIEL A ENGEL
金额:
$22.52万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-04-17 至 2005-11-30

项目摘要

项目成果

DANIEL A ENGEL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION:(Adapted from the Investigator's abstract): The adenovirus E1A protein induces imortalization and transformation of cells in culture and is therefore an excellent model for the study of cellular transformation. E1A binds specific cell proteins including the retinoblastoma protein (Rb) and p300/CBP proteins that control transcription, in part, by altering chromatin structure. E1A inhibits the function of the chromatin remodeling complex SWI/SNF, which interacts with Rb protein and possibly p300. Specific aim 1 proposes to define and characterize the mammalian SWI/SNF complex with respect to its role in regulation of transcription. It will be determined how the complex inhibits c-fos expression at the transcriptional level. The structural changes that accompany the inhibition of c-fos gene activity will be characterized, and assays will be developed to measure the physical association of SWI/SNF with specific mammalian promoters in vivo. Studies will characterize the effects of E1A on SWI/SNF processes. Specific aim 2 will use a yeast genetic approach to understand E1A inhibition of the SWI/SNF complex. The yeast proteins that interact with E1A will be identified and their influence on E1A activity will be determined. Similar studies will then be conducted in mammalian cells using the information gained from the yeast system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small molecule inhibitors of influenza virus nucleoprotein
  • 批准号:
    10255568
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2021
  • 负责人:
    DANIEL A ENGEL
  • 依托单位:
Discovery and development of broad spectrum anti-flaviviral drugs
  • 批准号:
    8277243
  • 项目类别:
  • 资助金额:
    $83.53万
  • 财政年份:
    2010
  • 负责人:
    DANIEL A ENGEL
  • 依托单位:
Discovery and development of broad spectrum anti-flaviviral drugs
  • 批准号:
    8466918
  • 项目类别:
  • 资助金额:
    $76.44万
  • 财政年份:
    2010
  • 负责人:
    DANIEL A ENGEL
  • 依托单位:
Discovery and development of broad spectrum anti-flaviviral drugs
  • 批准号:
    8661106
  • 项目类别:
  • 资助金额:
    $82.68万
  • 财政年份:
    2010
  • 负责人:
    DANIEL A ENGEL
  • 依托单位:
海外基金